Investigational metabolic peptide
Retatrutide
Retatrutide (LY3437943)
An investigational triple-receptor agonist studied in clinical research.
Research specification
20 mg per vial
Private quote available
For Research Purposes Only
Request a QuoteProduct research overview
Retatrutide is under clinical investigation for metabolic indications.